Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Preterm Infants: later-stage trial registry

1 of 3 indexed Preterm Infants trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Preterm Infants: 3 US clinical trials tracked, 1 recruiting.

Preterm Infants is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Abbott Nutrition, running 1 of these trials.

Enrollment posture brief

Registry condition preterm-infants

OPEN 1 | RECR 33% | LATE 2 | EARLY 1 | RANK #5209 | SPON 1

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Preterm Infants (this)33%
Open-enrollment share among volume-matched conditions near Preterm Infants

Preterm Infants lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Preterm Infants on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Preterm Infants is recruiting below its size-band peers.

    1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21Phase 32

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 2

Named interventions

Most-linked intervention names on Preterm Infants records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Preterm infant formula with added soluble lipids Other
1 trials
Preterm infant formulas and discharge formulas Other
1 trials
APC-0101 (SF-RI 1 surfactant for inhalation combined with a dedicated delivery system) Combination
1 trials
Control Other
1 trials
Placebo Dietary supplement
1 trials
Cholecalciferol Dietary supplement
1 trials

US sites by state

Facility locations filed on Preterm Infants trials. A trial with sites in several states counts in each.

New York 2 trials
Florida 2 trials
Alabama 2 trials
West Virginia 1 trials
Virginia 1 trials
Utah 1 trials
Texas 1 trials
Rhode Island 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Preterm Infants page

3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Preterm Infants condition card totals 3 registered trials; most-linked intervention Preterm infant formula with added soluble lipids; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.